Exploiting Real-Time Genomic Surveillance Data To Assess 4CMenB Meningococcal Vaccine Performance in Scotland, 2015 to 2022

The United Kingdom implemented the first national infant immunization schedule for the meningococcal vaccine 4CMenB (Bexsero) in September 2015, targeting serogroup B invasive meningococcal disease (IMD). Bexsero contains four variable subcapsular proteins, and postimplementation IMD surveillance wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodrigues, C. M. C., MacDonald, L., Ure, R., Smith, A., Cameron, J. C., Maiden, M. C. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10127610/
https://www.ncbi.nlm.nih.gov/pubmed/37036356
http://dx.doi.org/10.1128/mbio.00499-23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10127610/
https://www.ncbi.nlm.nih.gov/pubmed/37036356
http://dx.doi.org/10.1128/mbio.00499-23

Ejemplares similares